Terminology Service for NFDI4Health
All terms in CHEBI
| Label | Id | Description |
|---|---|---|
| N-[2-(3,4-dimethoxyphenyl)ethyl]-N'-(12-oxo-7,8,9,10-tetrahydro-6H-azepino[2,1-b]quinazolin-2-yl)oxamide | CHEBI_111348 | |
| N-(3-cyano-2-thiophenyl)-2-[4-(1,3,4-oxadiazol-2-yl)phenoxy]acetamide | CHEBI_111349 | |
| 1-[2-(2-methoxyanilino)-2-oxoethyl]-2-benzofuro[3,2-b]pyrrolecarboxylic acid methyl ester | CHEBI_111339 | |
| 5-[[(2S,3R)-2-[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorophenyl)-4-morpholinyl]methyl]-1,2-dihydro-1,2,4-triazol-3-one | CHEBI_94530 | |
| 2-[(4R,5S,6S,7R,9R,15R,16R)-6-[[(2R,3R,4R,5S,6R)-5-[[(2S,4R,5S,6S)-4,5-dihydroxy-4,6-dimethyl-2-oxanyl]oxy]-4-(dimethylamino)-3-hydroxy-6-methyl-2-oxanyl]oxy]-16-ethyl-4-hydroxy-15-[[(2R,3R,4R,5R,6R)-5-hydroxy-3,4-dimethoxy-6-methyl-2-oxanyl]oxymethyl]-5,9,13-trimethyl-2,10-dioxo-1-oxacyclohexadeca-11,13-dien-7-yl]acetaldehyde | CHEBI_94535 | |
| N-methylparoxetine | CHEBI_94536 | [A member of the class of benzodioxoles that is paroxetine in which the piperidine hydrogen is substituted by a methyl group. It is a drug impurity of the antidepressant, paroxetine.] |
| monofluorobenzenes | CHEBI_83575 | [Any member of the class of fluorobenzenes containing a mono- or poly-substituted benzene ring carrying a single fluorine substitutent.] |
| serotonin uptake inhibitor | CHEBI_50949 | [A compound that specifically inhibits the reuptake of serotonin in the brain. This increases the serotonin concentration in the synaptic cleft which then activates serotonin receptors to a greater extent.] |
| impurity | CHEBI_143130 | [A chemical role played by any unwanted chemical substance inside a confined amount of liquid, gas, or solid, which differs from the chemical composition of the material or compound. For example, an impurity can be an undesired by-product of a chemical reaction or manufacturing process, a drug contaminant, or can be created upon degradation during storage.] |
| paroxetine | CHEBI_7936 | [A benzodioxole that consists of piperidine bearing 1,3-benzodioxol-5-yloxy)methyl and 4-fluorophenyl substituents at positions 3 and 4 respectively; the (3S,4R)-diastereomer. Highly potent and selective 5-HT uptake inhibitor that binds with high affinity to the serotonin transporter (Ki = 0.05 nM). Ki values are 1.1, 350 and 1100 nM for inhibition of [3H]-5-HT, [3H]-l-NA and [3H]-DA uptake respectively. Displays minimal affinity for alpha1-, alpha2- or beta-adrenoceptors, 5-HT2A, 5-HT1A, D2 or H1 receptors at concentrations below 1000 nM, however displays weak affinity for muscarinic ACh receptors (Ki = 42 nM). Antidepressant and anxiolytic in vivo.] |
| CHEBI_94537 | CHEBI_94537 | |
| 4-(1-pyrrolidinyl)-1-(2,4,6-trimethoxyphenyl)-1-butanone | CHEBI_94538 | |
| N-hydroxy-3-[3-(phenylsulfamoyl)phenyl]-2-propenamide | CHEBI_94531 | |
| LSM-5352 | CHEBI_94532 | |
| chrysene-1,4-dione | CHEBI_94533 | |
| phenanthrenes | CHEBI_25961 | [Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.] |
| 2-methyl-4-(4-methyl-1-piperazinyl)-5H-thieno[3,2-c][1,5]benzodiazepine | CHEBI_94534 | |
| 2,5-bis[(4-hydroxy-3-methoxyphenyl)methylidene]-1-cyclopentanone | CHEBI_111330 | |
| 2-[(4-acetyloxyphenyl)methylidene]-7-methyl-3-oxo-5-(2-phenylethenyl)-5H-thiazolo[3,2-a]pyrimidine-6-carboxylic acid ethyl ester | CHEBI_111331 | |
| N-[(2S)-3-(1H-indol-3-yl)-1-[(3-methoxy-5-nitro-4-oxo-1-cyclohexa-2,5-dienylidene)methylhydrazo]-1-oxopropan-2-yl]carbamic acid 2-methylpropyl ester | CHEBI_111332 |